Immunovant Inc (IMVT)
26.87
+0.33
(+1.24%)
USD |
NASDAQ |
Nov 22, 16:00
26.88
+0.01
(+0.04%)
After-Hours: 20:00
Immunovant Enterprise Value: 3.471B for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 3.471B |
| November 21, 2024 | 3.423B |
| November 20, 2024 | 3.368B |
| November 19, 2024 | 3.229B |
| November 18, 2024 | 3.272B |
| November 15, 2024 | 3.436B |
| November 14, 2024 | 3.644B |
| November 13, 2024 | 3.769B |
| November 12, 2024 | 3.823B |
| November 11, 2024 | 4.098B |
| November 08, 2024 | 4.026B |
| November 07, 2024 | 3.920B |
| November 06, 2024 | 4.139B |
| November 05, 2024 | 3.978B |
| November 04, 2024 | 3.845B |
| November 01, 2024 | 3.841B |
| October 31, 2024 | 3.816B |
| October 30, 2024 | 3.950B |
| October 29, 2024 | 3.906B |
| October 28, 2024 | 3.917B |
| October 25, 2024 | 3.956B |
| October 24, 2024 | 3.997B |
| October 23, 2024 | 3.927B |
| October 22, 2024 | 3.865B |
| October 21, 2024 | 3.832B |
| Date | Value |
|---|---|
| October 18, 2024 | 3.846B |
| October 17, 2024 | 3.816B |
| October 16, 2024 | 3.802B |
| October 15, 2024 | 3.711B |
| October 14, 2024 | 3.842B |
| October 11, 2024 | 3.983B |
| October 10, 2024 | 3.914B |
| October 09, 2024 | 3.927B |
| October 08, 2024 | 3.867B |
| October 07, 2024 | 3.836B |
| October 04, 2024 | 3.999B |
| October 03, 2024 | 3.818B |
| October 02, 2024 | 3.854B |
| October 01, 2024 | 3.697B |
| September 30, 2024 | 3.706B |
| September 27, 2024 | 3.541B |
| September 26, 2024 | 3.584B |
| September 25, 2024 | 3.600B |
| September 24, 2024 | 3.655B |
| September 23, 2024 | 3.588B |
| September 20, 2024 | 3.718B |
| September 19, 2024 | 3.771B |
| September 18, 2024 | 3.670B |
| September 17, 2024 | 3.696B |
| September 16, 2024 | 3.748B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-99.99M
Minimum
Jun 16 2022
6.123B
Maximum
Dec 26 2023
2.002B
Average
1.679B
Median
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | -31.63M |
| Electromed Inc | 238.10M |
| Xtant Medical Holdings Inc | 83.10M |
| Myomo Inc | 147.33M |
| Catheter Precision Inc | 3.859M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -109.12M |
| Total Expenses (Quarterly) | 115.74M |
| EPS Diluted (Quarterly) | -0.74 |
| Earnings Yield | -8.26% |